logo
Plus   Neg
Share
Email

Semtech Q1 Tops Street, Outlook Strong; Shares Up 15%

Shares of Semtech Corp. (SMTC) gained over 15% on Wednesday's extended trading session after the semiconductor company's first-quarter results topped Wall Street estimates. The company also issued an outlook for the second quarter, which is expected to beat current estimates.

Net income for the quarter was $9.6 million or $0.15 per share, compared to $12.7 million or $0.19 per share last year. Adjusted earnings for the quarter was $0.35 per share, up from $0.34 per share last year.

Net sales for the quarter dropped to $132.7 million from $131.4 million last year.

Analysts polled by Thomson Reuters estimated earnings of $0.32 per share on revenues $129.28 million for the quarter.

Looking forward to the second quarter, Semtech expects adjusted earnings of $0.40 to $0.44 per share and sales of $138.0 million to $146.0 million. Analysts currently estimate earnings of $0.35 per share and revenues of $132.65 million.

SMTC closed Wednesday's trading at $50.21, up $1.16 or 2.36%, on the Nasdaq. The stock further gained $7.59 or 15.12% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT